Burrell Terry-Ann
Insider CIK 1786484 · RXRX Director · BEAM Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-07-01 | 2024-07-03 | 1,843 | — | $0 | 71,254 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2024-06-03 | 2024-06-05 | 26,193 | — | $0 | 26,193 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-06-03 | 2024-06-05 | 13,097 | — | $0 | 69,411 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2024-04-26 | 2024-04-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award | 2024-04-26 | 2024-04-29 | 12,500 | — | $0 | 82,637 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-04-01 | 2024-04-03 | 1,467 | — | $0 | 56,314 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2024-04-01 | 2024-04-03 | 5,446 | $32.12 | $174.9K | 70,137 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award | 2024-03-31 | 2024-04-02 | 27,500 | — | $0 | 75,583 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 55,000 | $24.40 | $1.34M | 55,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-07-13 | 2023-07-14 | 8,275 | $12.59 | $104.2K | 54,847 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-07-12 | 2023-07-14 | 78,071 | $12.15 | $948.6K | 69,474 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-07-12 | 2023-07-14 | 24,302 | $11.25 | $273.4K | 147,545 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-07-12 | 2023-07-14 | 3,195 | $13.18 | $42.1K | 66,279 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2023-07-12 | 2023-07-14 | 3,157 | $14.08 | $44.5K | 63,122 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2023-06-16 | 2023-06-21 | 25,224 | — | $0 | 25,224 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-06-16 | 2023-06-21 | 12,612 | — | $0 | 171,847 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2023-04-04 | 2023-04-05 | 2,186 | $29.09 | $63.6K | 47,117 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2023-04-03 | 2023-04-05 | 2,454 | $30.31 | $74.4K | 49,303 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award | 2023-03-31 | 2023-03-31 | 20,000 | — | $0 | 51,277 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2023-01-31 | 2023-04-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2023-01-31 | 2023-03-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise deriv | 2023-01-27 | 2023-01-30 | 36,152 | — | $0 | 185,565 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise | 2023-01-27 | 2023-01-30 | 36,152 | $13.68 | $494.6K | 67,429 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2023-01-27 | 2023-01-30 | 36,152 | $45.08 | $1.63M | 31,277 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise deriv | 2023-01-26 | 2023-01-30 | 1,102 | — | $0 | 221,717 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2023-01-26 | 2023-01-30 | 1,102 | $45.16 | $49.8K | 31,277 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise | 2023-01-26 | 2023-01-30 | 1,102 | $13.68 | $15.1K | 32,379 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise deriv | 2023-01-24 | 2023-01-25 | 14,810 | — | $0 | 222,819 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise | 2023-01-24 | 2023-01-25 | 14,810 | $13.68 | $202.6K | 46,087 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2023-01-24 | 2023-01-25 | 14,810 | $45.01 | $666.6K | 31,277 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise deriv | 2023-01-23 | 2023-01-25 | 5,426 | — | $0 | 237,629 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2023-01-23 | 2023-01-25 | 5,426 | $45.02 | $244.3K | 31,277 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise | 2023-01-23 | 2023-01-25 | 5,426 | $13.68 | $74.2K | 36,703 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise deriv | 2023-01-18 | 2023-01-20 | 39,886 | — | $0 | 243,055 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2023-01-18 | 2023-01-20 | 47,195 | $45.14 | $2.13M | 31,277 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise | 2023-01-18 | 2023-01-20 | 39,886 | $13.68 | $545.6K | 78,472 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-01-03 | 2023-01-05 | 1,821 | — | $0 | 159,235 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-10-03 | 2022-10-05 | 1,265 | — | $0 | 157,414 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-07-01 | 2022-07-06 | 1,631 | — | $0 | 156,149 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2022-06-14 | 2022-06-16 | 36,290 | — | $0 | 36,290 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-06-14 | 2022-06-16 | 18,145 | — | $0 | 154,518 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-04-01 | 2022-04-05 | 1,788 | — | $0 | 136,373 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award | 2022-03-31 | 2022-04-04 | 15,000 | — | $0 | 40,065 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2022-03-31 | 2022-04-04 | 1,787 | $59.11 | $105.6K | 38,278 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-01-03 | 2022-01-05 | 763 | — | $0 | 134,585 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-10-01 | 2021-10-05 | 629 | — | $0 | 133,822 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-07-01 | 2021-07-06 | 382 | — | $0 | 133,193 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise deriv | 2021-06-30 | 2021-07-02 | 30,000 | — | $0 | 282,941 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise | 2021-06-30 | 2021-07-02 | 30,000 | $13.68 | $410.4K | 54,809 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-06-30 | 2021-07-02 | 15,000 | $117.00 | $1.75M | 39,809 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-06-30 | 2021-07-02 | 15,000 | $127.00 | $1.91M | 24,809 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise deriv | 2021-06-28 | 2021-06-30 | 45,000 | — | $0 | 312,941 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-06-28 | 2021-06-30 | 1,100 | $103.86 | $114.2K | 68,709 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise | 2021-06-28 | 2021-06-30 | 45,000 | $13.68 | $615.6K | 69,809 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-06-28 | 2021-06-30 | 19,800 | $109.41 | $2.17M | 24,809 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-06-28 | 2021-06-30 | 1,880 | $104.63 | $196.7K | 66,829 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-06-28 | 2021-06-30 | 5,220 | $105.34 | $549.9K | 61,609 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-06-28 | 2021-06-30 | 4,803 | $108.45 | $520.9K | 44,609 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-06-28 | 2021-06-30 | 8,907 | $106.13 | $945.3K | 52,702 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-06-28 | 2021-06-30 | 3,290 | $107.20 | $352.7K | 49,412 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 404,688 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 404,688 | — | $0 | 404,688 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 12,500 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 126,561 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-04-20 | 2021-04-22 | 126,561 | — | $0 | 126,561 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 6,250 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 6,250 | — | $0 | 132,811 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-04-16 | 2021-04-19 | 6,250 | — | $0 | 126,561 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2021-04-15 | 2021-04-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2021-03-31 | 2021-04-02 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award | 2021-03-31 | 2021-04-02 | 17,500 | — | $0 | 24,809 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise deriv | 2021-01-04 | 2021-01-05 | 25,000 | — | $0 | 357,941 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-05 | 800 | $78.05 | $62.4K | 31,509 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise | 2021-01-04 | 2021-01-05 | 25,000 | $13.68 | $342.0K | 32,309 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-05 | 2,449 | $80.25 | $196.5K | 27,109 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-05 | 6,509 | $81.26 | $528.9K | 20,600 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-05 | 5,296 | $82.44 | $436.6K | 15,304 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-05 | 7,095 | $83.15 | $589.9K | 8,209 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-05 | 900 | $83.89 | $75.5K | 7,309 | SEC↗ |
| BEAM Beam Therapeutics Inc. | S Sale | 2021-01-04 | 2021-01-05 | 1,951 | $79.21 | $154.5K | 29,558 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise deriv | 2020-09-18 | 2020-09-21 | 7,309 | — | $0 | 382,941 | SEC↗ |
| BEAM Beam Therapeutics Inc. | M Exercise | 2020-09-18 | 2020-09-21 | 7,309 | $13.68 | $100.0K | 7,309 | SEC↗ |